Search
Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.
Dendritic cells, the guards of the immune system, have a previously unrecognized division of labor.
An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.
New findings from experiments done in mice suggest a surprising cause of common neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.
The updated versions can survive longer in the body while still packing a punch against cancer.
Grab your popcorn and pull up a chair for these video shorts of cell signaling in early mouse development.
Dr. Lima is one of 27 biomedical researchers in the country being named an HHMI investigator today. This elite group of scientists will receive approximately $150 million over the next five years.
A combination immunotherapy approach using CAR T cells could be an effective new way to treat mesothelioma.
Surprise! It has to do with metabolism.